Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus

Go back to Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus
(NASDAQ: APYX) Delayed: 3.06 +0.05 (1.66%)
Previous Close $3.01    52 Week High
Open $3.04    52 Week Low
Day High $3.11    P/E N/A 
Day Low $3.04    EPS
Volume 6,032